Internal Medicine
RSSArticles
-
Infectious Disease Alert Updates
Changing Herpes Zoster Risk in Adults; Trends in Herpes Zoster Risk Among Children
-
A Maternal Antibody Protects Infants From Severe Malaria
Transplacental antibodies against Plasmodium falciparum Schizont Egress Antigen-1 may protect infants from severe malarial infection during the first year of life. This new knowledge about these antibodies potentially can inform vaccine development.
-
Mechanism of Persistence of Moraxella catarrhalis in Patients With Chronic Obstructive Pulmonary Disease
This study examines the mechanism that allows Moraxella catarrhalis to persist in some patients with chronic obstructive pulmonary disease.
-
Infective Endocarditis Prevalence in Dutch Patients With Positive Blood Cultures
Data from a nationwide registry in Denmark from 2010 to 2017 showed that patients with Enterococcus faecalis bacteremia had the highest prevalence of infective endocarditis (16.7%), followed by Staphylococcus aureus (10.1%) and Streptococcus spp. (7.3%).
-
Travel Medicine 2019 — A Conference Report
The International Society of Travel Medicine met in Washington, DC, from June 5-9.
-
Measles — It’s Back!
The number of measles cases in the United States has exceeded 1,000 so far in 2019, the largest number in a quarter of a century.
-
Reader Survey Available
We’d love to hear from you how we can do better!
-
Midazolam Nasal Spray (Nayzilam) CIV
Midazolam nasal spray should be prescribed to treat acute intermittent, stereotypic episodes of frequent seizure activity (acute repetitive seizures, seizure clusters) that are distinct from the patient’s usual seizure patterns.
-
Physicians Cannot Agree on Who Benefits From ICU Care
The authors of a study randomizing U.S. critical care physicians to analyze hypothetical patient vignettes found that estimates of whether a patient would benefit from ICU care were widely dissimilar among those surveyed and influenced by factors unrelated to severity of illness.
-
Does Hormone Therapy Increase the Risk of Alzheimer’s Disease?
The results of a large Finnish case-control study suggest that postmenopausal hormone therapy results in a 9-17% increase in the risk of Alzheimer’s disease. However, the small effect size, and likely confounding of use effect, does not provide strong evidence for a causal relationship.